INS and preeclampsia: Our finding that the need of insulin supplementation in pregnant women under GCs treatment receiving αMD for gestational hypertension is reduced by 30% compared to women not receiving αMD may raise the hypothesis that αMD may ameliorate glucose levels in pregnancy by increasing insulin sensitivity.